Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-20 8:15 PM View:  | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 605,668 | -- | -- | (100%) 605.67K to 0 | |
| 19-Nov-20 8:15 PM View: | Yarno Wendy L Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 5,508 | -- | -- | (100%) 5.51K to 0 | |
| 19-Nov-20 8:21 PM View: | Harris Taylor C. Chief Financial Officer | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 42,559 | -- | -- | (100%) 42.56K to 0 | |
| 19-Nov-20 8:13 PM View: | Waynick Denelle J Chief Legal Officer | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 25,000 | -- | -- | (100%) 25.0K to 0 | |
| 19-Nov-20 8:26 PM View: | Meeker David P Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 19-Nov-20 8:20 PM View: | Agarwal Sunil Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 19-Nov-20 8:19 PM View: | Perry Mark L Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 29,508 | -- | -- | (100%) 29.51K to 0 | |
| 19-Nov-20 8:16 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 19-Nov-20 8:15 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 141,405 | -- | -- | (19%) 747.07K to 605.67K | |
| 19-Nov-20 8:20 PM View: | Fairey William EVP, Chief Commercial Officer | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 42,199 | -- | -- | (100%) 42.2K to 0 | |
| 19-Nov-20 8:16 PM View: | Popovits Kimberly J Director | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 19-Nov-20 8:26 PM View: | McDowell Robert Scott Chief Scientific Officer | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 36,616 | -- | -- | (100%) 36.62K to 0 | |
| 19-Nov-20 8:19 PM View: | Bauer Jake Chief Business Officer | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 90,209 | -- | -- | (100%) 90.21K to 0 | |
| 07-Jul-20 5:39 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 02-Jul-20 | Private Sale (Planned) | 5,000 | $93.98 | $469,909.00 | (< 1%) 629.79K to 624.79K | |
| 01-Jul-20 7:28 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 30-Jun-20 | Private Option Sale | 21,629 | $96.60 | $2,089,360.00 | (100%) 21.63K to 0 | |
| 01-Jul-20 7:28 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 30-Jun-20 | Option Exercise | 21,629 | $11.69 | $252,843.00 | 100% 0 to 21.63K | |
| 01-Jul-20 7:28 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 29-Jun-20 | Option Exercise | 371 | $11.69 | $4,336.99 | 100% 0 to 0.37K | |
| 01-Jul-20 7:28 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 29-Jun-20 | Private Option Sale | 371 | $98.68 | $36,611.10 | (100%) 0.37K to 0 | |
| 16-Jun-20 6:06 PM View: | Meeker David P Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 16-Jun-20 6:09 PM View: | Agarwal Sunil Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 16-Jun-20 6:02 PM View: | Yarno Wendy L Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 163% 1.41K to 3.71K | |
| 16-Jun-20 6:07 PM View: | Popovits Kimberly J Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 16-Jun-20 6:00 PM View: | Cranston Mary B Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 16-Jun-20 6:03 PM View: | Perry Mark L Director | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 9% 25.41K to 27.71K | |
| 04-Jun-20 4:24 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 02-Jun-20 | Private Sale (Planned) | 5,000 | $102.84 | $514,208.00 | (< 1%) 634.79K to 629.79K | |
| 20-May-20 4:55 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 18-May-20 | Private Sale (Planned) | 10,000 | $125.00 | $1,250,000.00 | (2%) 644.79K to 634.79K | |
| 13-May-20 5:15 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 11-May-20 | Private Sale (Planned) | 25,000 | $101.86 | $2,546,480.00 | (4%) 669.79K to 644.79K | |
| 06-May-20 7:07 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 04-May-20 | Private Sale (Planned) | 5,000 | $58.48 | $292,388.00 | (< 1%) 674.79K to 669.79K | |
| 04-May-20 5:34 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 30-Apr-20 | Grant | 421 | $50.41 | $21,224.10 | < 1% 662.87K to 663.29K | (6%) |
| 04-May-20 5:34 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 30-Apr-20 | Option Exercise | 11,500 | $1.51 | $17,328.20 | 2% 663.29K to 674.79K | |
| 04-Jun-20 4:20 PM View: | Bauer Jake Chief Business Officer | Myokardia, Inc. (MYOK) | 30-Apr-20 | Grant | 293 | $50.41 | $14,771.20 | < 1% 57.49K to 57.78K | (6%) |
| 20-Apr-20 6:10 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 20-Apr-20 | Gift | 122,661 | -- | -- | (16%) 785.53K to 662.87K | |
| 20-Apr-20 6:10 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 17-Apr-20 | Gift | 200,865 | -- | -- | 26% 785.53K to 986.39K | |
| 20-Apr-20 6:10 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 17-Apr-20 | Gift | 200,865 | -- | -- | (20%) 986.39K to 785.53K | |
| 20-Apr-20 6:10 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 16-Apr-20 | Private Sale (Planned) | 1,000 | $55.00 | $55,000.00 | (< 1%) 786.53K to 785.53K | |
| 10-Apr-20 6:27 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 08-Apr-20 | Private Sale (Planned) | 1,500 | $50.00 | $75,000.00 | (< 1%) 665.37K to 663.87K | |
| 07-Apr-20 5:42 PM View: | Harris Taylor C. Chief Financial Officer | Myokardia, Inc. (MYOK) | 06-Apr-20 | Market Option Sale | 1,305 | $46.99 | $61,322.00 | (15%) 8.74K to 7.44K | |
| 07-Apr-20 5:42 PM View: | Harris Taylor C. Chief Financial Officer | Myokardia, Inc. (MYOK) | 04-Apr-20 | Option Exercise | 3,750 | -- | -- | 75% 4.99K to 8.74K | |
| 06-Apr-20 4:06 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 02-Apr-20 | Market Sale (Planned) | 2,500 | $44.77 | $111,917.00 | (< 1%) 667.87K to 665.37K | (5%) |
| 04-Mar-20 5:42 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 02-Mar-20 | Private Sale (Planned) | 5,000 | $64.45 | $322,246.00 | (< 1%) 672.87K to 667.87K | |
| 05-Feb-20 8:22 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 03-Feb-20 | Private Sale (Planned) | 5,000 | $69.36 | $346,821.00 | (< 1%) 677.85K to 672.85K | |
| 03-Feb-20 8:55 PM View: | Fairey William See Remarks | Myokardia, Inc. (MYOK) | 01-Feb-20 | Private Option Sale | 2,899 | $68.04 | $197,248.00 | (36%) 8.13K to 5.23K | |
| 03-Feb-20 8:55 PM View: | Fairey William See Remarks | Myokardia, Inc. (MYOK) | 01-Feb-20 | Option Exercise | 8,125 | -- | -- | 100% 0 to 8.13K | |
| 14-Jan-20 8:26 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 14-Jan-20 | Private Sale (Planned) | 5,000 | $75.39 | $376,964.00 | (< 1%) 682.85K to 677.85K | |
| 07-Jan-20 7:39 PM View: | McDowell Robert Scott Chief Scientific Officer | Myokardia, Inc. (MYOK) | 06-Jan-20 | Private Sale | 2,650 | $68.45 | $181,395.00 | (33%) 8.03K to 5.38K | |
| 07-Jan-20 5:15 PM View: | Bauer Jake Chief Business Officer | Myokardia, Inc. (MYOK) | 06-Jan-20 | Private Option Sale | 2,466 | $68.45 | $168,800.00 | (4%) 59.96K to 57.49K | |
| 07-Jan-20 7:39 PM View: | Harris Taylor C. Chief Financial Officer | Myokardia, Inc. (MYOK) | 06-Jan-20 | Private Sale | 1,683 | $68.45 | $115,203.00 | (25%) 6.68K to 4.99K | |
| 07-Jan-20 7:39 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 06-Jan-20 | Private Sale | 12,687 | $68.45 | $868,439.00 | (2%) 695.54K to 682.85K | |
| 07-Jan-20 7:36 PM View: | Ladd Cynthia J General Counsel | Myokardia, Inc. (MYOK) | 06-Jan-20 | Private Sale | 1,849 | $68.45 | $126,566.00 | (39%) 4.7K to 2.85K | |
| 03-Jan-20 8:18 PM View: | Gianakakos Anastasios President and CEO Director | Myokardia, Inc. (MYOK) | 03-Jan-20 | Planned Private Option Sale | 5,000 | $71.80 | $359,008.00 | (< 1%) 700.54K to 695.54K |
